Your session is about to expire
← Back to Search
Electrical Neuromodulation for Spasticity
Study Summary
This trial will test the efficacy of four different transcutaneous spinal stimulation (TSS) protocols on spasticity in people with chronic spinal cord injury (SCI). TSS is a non-pharmacological approach that uses electrical stimulation to modulate the excitability of the lumbosacral network. This trial will use a prospective, experimental, cross-over, assessor-masked study design in 12 individuals with chronic SCI. The study will examine the effect of TSS on spasticity on a short- and long-term basis.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a medical device implanted in your body that actively delivers medication.I cannot have electrodes placed on my skin due to skin conditions.I have a spinal cord injury graded A-D.I experience mild or greater leg spasticity, rating it above 3 out of 10.I have implants like plates or screws between my T10 and L3 vertebrae.You need a ventilator to help you breathe.I currently have an infection.I am 18 years old or older.I suspect my spinal condition is getting worse.My spinal cord injury is below the T11 vertebra.Your injury happened more than 6 months ago.
- Group 1: Neuromodulation with 50 Hz and low intensity
- Group 2: Neuromodulation with 50 Hz and high intensity
- Group 3: Neuromodulation with 100 Hz and low intensity
- Group 4: Neuromodulation with 100 Hz and high intensity
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there still available opportunities to partake in this trial?
"The trial is currently seeking participants. According to its listing on clinicaltrials.gov, it was established in August 16th 2022 and last amended three days later."
How many participants have signed up for this research endeavor?
"Affirmative. According to the information available on clinicaltrials.gov, this medical trial first appeared on August 16th 2022 and was recently updated on the 19th of that month. The study is recruiting 12 people from two different facilities for participation."
What are the key purposes of this research initiative?
"The primary aim of this study, which will be evaluated within a Before and after an intervention session (30 minutes) time frame is to ascertain any Changes in posterior root reflex amplitude following the administration of the treatment. Additionally, secondary outcomes such as modifications to Spinal cord Assessment Tool for Spastic Reflexes (summed 4-point scale encompassing ankle clonus, flexor & extensor leg spasms), Modified Ashworth Scale (a 0 - 40 score range gauging muscle tone across 10 tested muscles with '1+' scoring category valued at 1.5) and Modified Ashworth Scale post one week shall also be monitored."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What state do they live in?
Share this study with friends
Copy Link
Messenger